- Home
- ZLAB vs STRRP Comparison
ZLAB vs STRRP Comparison
Compare ZLAB & STRRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- STRRP
- Stock Information
- Founded
- ZLAB 2013
- STRRP N/A
- Country
- ZLAB China
- STRRP United States
- Employees
- ZLAB N/A
- STRRP 194
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZLAB Health Care
- STRRP Health Care
- Exchange
- ZLAB Nasdaq
- STRRP Nasdaq
- Market Cap
- ZLAB 3.6B
- STRRP N/A
- IPO Year
- ZLAB 2017
- STRRP N/A
- Fundamental
- Price
- ZLAB $32.54
- STRRP $9.23
- Analyst Decision
- ZLAB Buy
- STRRP
- Analyst Count
- ZLAB 5
- STRRP 0
- Target Price
- ZLAB $54.28
- STRRP N/A
- AVG Volume (30 Days)
- ZLAB 781.8K
- STRRP N/A
- Earning Date
- ZLAB 08-05-2025
- STRRP N/A
- Dividend Yield
- ZLAB N/A
- STRRP N/A
- EPS Growth
- ZLAB N/A
- STRRP N/A
- EPS
- ZLAB N/A
- STRRP N/A
- Revenue
- ZLAB $418,326,000.00
- STRRP N/A
- Revenue This Year
- ZLAB $44.07
- STRRP N/A
- Revenue Next Year
- ZLAB $49.13
- STRRP N/A
- P/E Ratio
- ZLAB N/A
- STRRP N/A
- Revenue Growth
- ZLAB 43.72
- STRRP N/A
- 52 Week Low
- ZLAB $16.01
- STRRP N/A
- 52 Week High
- ZLAB $44.34
- STRRP N/A
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- STRRP 55.69
- Support Level
- ZLAB $34.26
- STRRP $9.01
- Resistance Level
- ZLAB $35.72
- STRRP $9.29
- Average True Range (ATR)
- ZLAB 1.12
- STRRP 0.03
- MACD
- ZLAB -0.54
- STRRP 0.03
- Stochastic Oscillator
- ZLAB 3.83
- STRRP 82.86
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.